About 500 Mg Ramucirumab
Experience unbeatable efficacy with 500 Mg Ramucirumab, designed for customizable hospital oncology applications. This gilt-edged, prescription-only injection comes in a single-use vial (500 mg/50 ml), radiantly clear to slightly yellow, and odorless. Compatible with 0.9% sodium chloride and 5% glucose solutions, it is sterile, preservative-free, and ready-to-use for intravenous administration. Manufactured by a leading pharmaceuticals company, Ramucirumab is cost-effective, US FDA, EMA, and CDSCO approved, ensuring premium quality. Ideal for treating advanced/metastatic gastric, colorectal, non-small cell lung, and hepatocellular cancers. Minimum order quantities are tailored to your needs.
Efficient Application and Features Highlight
500 Mg Ramucirumab is administered intravenously, following hospital protocols under professional supervision for optimum safety. Features include a sterile, preservative-free, ready-to-use formulation housed in a single-use vial. The solution is clear to slightly opalescent and colorless to slightly yellow, ensuring precise dosing. Compatible with 0.9% sodium chloride and 5% glucose infusion solutions, this product delivers reliable and efficient oncology support in a cost-effective manner while meeting premium standards.
Sample Policy & Delivery Assurance
Our premium sample policy provides transparency and flexibility, ensuring you receive exactly what you expect with each Ramucirumab order. Samples can be requested at an asking price set by the supplier. Delivery is managed via exceptional transport services through India's finest FOB ports, with swift dispatch ensuring a seamless procurement experience. Typically, delivery times are customized to meet your scheduling requirements, offering assurance for your hospital's oncology needs.
FAQ's of 500 Mg Ramucirumab:
Q: How should 500 Mg Ramucirumab be administered for optimal results?
A: 500 Mg Ramucirumab should be administered intravenously by a healthcare professional in a hospital setting, following the recommended dilution with compatible infusion solutions and adhering to prescribed dosage and safety protocols.
Q: What are the main indications for prescribing Ramucirumab 500 Mg injection?
A: Ramucirumab 500 Mg is indicated for the treatment of advanced or metastatic gastric cancer, colorectal cancer, non-small cell lung cancer, and hepatocellular carcinoma as part of oncology therapy.
Q: When should Ramucirumab not be used?
A: Ramucirumab should not be used in patients with known hypersensitivity to the active ingredient or any of its excipients, as outlined in the product's safety profile.
Q: Where should 500 Mg Ramucirumab vials be stored to maintain quality?
A: Ramucirumab vials should be stored in a refrigerator at temperatures between 2C to 8C, protected from light, and must not be frozen to ensure potency and shelf life.
Q: What is the process for ordering and receiving Ramucirumab?
A: Ordering Ramucirumab is tailored to your requirements, with minimum quantities as specified by the supplier. Delivery employs premium transport services through India's leading FOB ports, assuring timely and secure arrival.
Q: How does Ramucirumab benefit oncology patients?
A: Ramucirumab provides a gilt-edged option for targeted cancer therapy, offering sterile, ready-to-use intravenous treatment that is both effective and approved by major global regulatory authorities.